Amylyx Pharmaceuticals (AMLX)
(Delayed Data from NSDQ)
$4.05 USD
+0.09 (2.27%)
Updated Dec 20, 2024 04:00 PM ET
After-Market: $4.04 -0.01 (-0.25%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/27/25 |
---|---|
Current Quarter | -0.49 |
EPS Last Quarter | -0.53 |
Last EPS Surprise | -12.77% |
ABR | 2.14 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.29 |
Next Year | -1.50 |
EPS (TTM) | -1.65 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 88.02M | NA |
# of Estimates | NA | NA | 2 | NA |
High Estimate | NA | NA | 88.04M | NA |
Low Estimate | NA | NA | 88.00M | NA |
Year ago Sales | 108.45M | 88.64M | 380.79M | 88.02M |
Year over Year Growth Est. | NA | NA | -76.88% | NA |
Earnings Estimates
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.49 | NA | -4.29 | -1.50 |
# of Estimates | 2 | NA | 3 | 3 |
Most Recent Consensus | -0.51 | NA | -4.39 | -1.01 |
High Estimate | -0.46 | NA | -4.12 | -1.01 |
Low Estimate | -0.51 | NA | -4.39 | -1.75 |
Year ago EPS | 0.07 | -0.46 | 0.70 | -4.29 |
Year over Year Growth Est. | -800.00% | NA | -712.86% | 65.03% |
Agreement - Estimate Revisions
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | NA | 0 | 0 |
Up Last 30 Days | 0 | NA | 0 | 0 |
Up Last 60 Days | 1 | NA | 0 | 1 |
Down Last 7 Days | 0 | NA | 0 | 0 |
Down Last 30 Days | 0 | NA | 0 | 0 |
Down Last 60 Days | 1 | NA | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.49 | NA | -4.29 | -1.50 |
7 Days Ago | -0.49 | NA | -4.29 | -1.50 |
30 Days Ago | -0.49 | NA | -4.29 | -1.50 |
60 Days Ago | -0.49 | NA | -3.09 | -1.53 |
90 Days Ago | -0.49 | NA | -3.09 | -1.58 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (12/2024) |
Next Qtr (3/2025) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.49 | NA | -4.29 | -1.50 |
Zacks Consensus Estimate | -0.49 | NA | -4.29 | -1.50 |
Earnings ESP | 0.00% | NA | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (9/2024) |
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.53 | -0.73 | -0.46 | 0.07 | NA |
Estimate | -0.47 | -0.38 | 0.24 | 0.20 | NA |
Difference | -0.06 | -0.35 | -0.70 | -0.13 | -0.31 |
Surprise | -12.77% | -92.11% | -291.67% | -65.00% | -115.39% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more